Francois J. Lebel
2021
In 2021, Francois J. Lebel earned a total compensation of $2.4M as Executive Vice President and Chief Medical Officer at Spectrum Pharmaceuticals, a 7% increase compared to previous year.
Compensation breakdown
| Bonus | $216,000 |
|---|---|
| Option Awards | $1,059,371 |
| Salary | $540,000 |
| Stock Awards | $392,700 |
| Other | $161,960 |
| Total | $2,370,031 |
Lebel received $1.1M in option awards, accounting for 45% of the total pay in 2021.
Lebel also received $216K in bonus, $540K in salary, $392.7K in stock awards and $162K in other compensation.
Rankings
In 2021, Francois J. Lebel's compensation ranked 5,371st out of 12,406 executives tracked by ExecPay. In other words, Lebel earned more than 56.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,371 out of 12,406 | 57th |
Division Manufacturing | 2,261 out of 5,492 | 59th |
Major group Chemicals And Allied Products | 984 out of 2,368 | 58th |
Industry group Drugs | 876 out of 2,089 | 58th |
Industry Pharmaceutical Preparations | 628 out of 1,536 | 59th |
Pay ratio
| Francois J. Lebel's Pay | $2,370,031 |
|---|---|
| Median Employee's Pay | $158,327 |
| Pay Ratio | 15to 1 |
In 2021, the annual total compensation of Francois J. Lebel was $2,370,031.
The annual total compensation of the median employee at Spectrum Pharmaceuticals was $158,327.
The ratio of Francois J. Lebel's pay to the pay of median employee was therefore 15 to one.
Source: SEC filing on April 27, 2022.
Lebel's colleagues
We found four more compensation records of executives who worked with Francois J. Lebel at Spectrum Pharmaceuticals in 2021.